Perspective · 10 Sep 2026
Conference abstractPublished 29 Jun 2017
In silico study of lipids associated in non-bilayer phospholipid arrangements
ENCB- The National Polytechnic Institute, Mexico; Computer Research Center-IPN, Mexico; National Autonomous University of Mexico, Mexico
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: Systemic lupus erythematous (SLE) is an autoimmune, chronic and multifactorial disease. For SLE study, some animal models had been developed, and our lab has one. Our model was obtained by administering a different lipid bilayer structure called non-bilayer phospholipid arrangements. These non-bilayer phospholipid arrangements can be stabilized with drugs such as chlorpromazine or procainamide and specifically in female mice, causing a disease very similar to human SLE. To help understand how these lipid structures in the development of the disease involved, we used bioinformatics tools to understand how they form, and now we’ll try to extrapolate this to explain some of the symptoms faced by patients with SLE. Methodology & Theoretical Orientation: A molecular simulation was established using all the conditions used in our murine model with chlorpromazine and was created with GROMACS software. Analyses of results were made with GROMACS utilities, proprietary Python programs and VMD tools. Findings: With our simulation strategy, we were able to observe differences between diverse lipidic environments with one or various molecules of chlorpromazine. Also, we have started new simulations to improve our strategy and get more useful information for our molecular knowledge of the models and the etiology of the human disease. Conclusion & Significance: These findings help us to understand how the models are triggered and give us clues about how to improve them for a further research of how SLE is initiated in humans. That probably will contribute to the improvement of the models and support our novel theory about the etiology of the SLE disease in humans.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Sanchez B Sandra”
- BylineArticles whose byline prints “Landa S Carla E”
- BylineArticles whose byline prints “Resendiz M Claudia A”
- BylineArticles whose byline prints “Wong B Carlos”
- BylineArticles whose byline prints “Wong R Carlos”
- BylineArticles whose byline prints “Yanez M Cornelio”
- BylineArticles whose byline prints “Castelan V Juan Arturo”
- BylineArticles whose byline prints “Dominguez D Laura”
